CCL4-neutralizing antibodies effectively inhibited macrophage-induced prostate tumorigenic signaling, while CCL4 upregulation was associated with increased Snail expression and p53/PTEN down-regulation in high-grade prostatic intraepithelial neoplasia and prostate cancer [54]. Here, CCL4 is linked to prostate cancer.